3118.TWO Level Biotechnology

Healthcare Biotechnology Taiwan OTC Exchange
30.30 TWD
Close of Nov 6, 2026
30.10 34.70
Market cap
TWD 983M
P/E
13.0x
P/B
1.83x
ROE
11.4%
Dividend yield
5.94%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 3118.TWO undervalued?

Graham number
Price30.30
Graham value29.48
Premium2.8%

3118.TWO trades 2.8% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Level Biotechnology fundamental analysis

No fundamental analysis for Level Biotechnology yet.

Level Biotechnology stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Level Biotechnology

Level Biotechnology Inc. engages in marketing and distributing cell culture, immunology, and molecular biology products in Taiwan. The company markets and distributes biomedical precision equipment. It also provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production. In addition, it offers preclinical research services to the biotech, pharmaceutical, medical device, animal health, and agrichemical industries…

Full company profile